Johann Hari: They’re Lying To You About The Side Effects Of Ozempic!

In this episode, Johann Hari discusses his investigation into Ozempic and other new weight loss drugs, exploring both their extraordinary benefits and disturbing risks. Hari explains how he discovered the drug and became interested in investigating it thoroughly, examining what Ozempic actually is, how it works in the brain to suppress appetite, and the significant impact it has on neural pathways related to food and cravings.

The conversation delves into the mechanisms of how Ozempic functions, including a discussion of the Cheesecake Park experiment that illustrates its power to override food motivation. Hari challenges the narrative that obesity is simply a matter of personal choice, arguing instead that obesogenic environments and food engineering play crucial roles in weight gain. He explores the phenomenon of addiction transfer, where people may substitute one compulsive behavior for another when using the drug.

A major focus of the episode addresses side effects that manufacturers have not been transparent about. Hari details the real risks of muscle loss, the phenomenon known as Ozempic face resulting from rapid fat loss, and more concerning issues including suicide risk and documented fatalities. He discusses where people can purchase Ozempic, the origins of the drug, and presents compelling reasons why people should carefully consider whether to take it.

The conversation examines whether Ozempic might function as an addiction killer by reducing dopamine-driven compulsive behaviors, potentially offering benefits beyond weight loss for addiction treatment. Hari addresses the debate around whether diabetes is more deadly than weight loss drugs and weighs the various downsides against potential benefits. He speculates about a future where most people might be on Ozempic and questions whether the government should intervene in its distribution and use.

Another critical discussion point is weight gain after stopping Ozempic, which Hari indicates is nearly universal. The episode addresses the growing use of Ozempic among children and explores how celebrities taking the drug while hiding the truth affects public perception. The conversation includes discussion of Oprah's weight loss journey and raises important questions about whether people will simply exercise less if they can achieve weight loss through medication.

Hari addresses the high demand for Ozempic and the resulting issues, including shortage concerns affecting diabetic patients who genuinely need the medication. Throughout the episode, the discussion emphasizes the complexity of these new drugs, presenting a balanced view that acknowledges both remarkable benefits and serious, often-hidden risks that individuals and society must carefully consider.